NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION Trademark
Trademark Overview
On Thursday, August 24, 2023, a trademark application was filed for NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION with the United States Patent and Trademark Office. The USPTO has given the NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark a serial number of 98149193. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by National Community Oncology Dispensing Association, Inc.. The NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Developing accreditation standards for dispensing pharmacy within an oncology center of excellence to the order and specification of others; Evaluating organizations to determine whether the organizations conform to an established accreditation standard; Testing and evaluating accreditation standards for dispensing pharmacy within an oncology center of excellence to the order and specification of others; Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards; Testing, analysis and evaluation of dispensing pharmacy within an oncology center of excellence to determine conformity with established accreditation standards
General Information
| Serial Number | 98149193 |
| Word Mark | NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION |
| Filing Date | Thursday, August 24, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 28, 2024 |
| Registration Number | 7401968 |
| Registration Date | Tuesday, May 28, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 12, 2024 |
Trademark Statements
| NOT AVAILABLE | "CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION" |
| Goods and Services | Developing accreditation standards for dispensing pharmacy within an oncology center of excellence to the order and specification of others; Evaluating organizations to determine whether the organizations conform to an established accreditation standard; Testing and evaluating accreditation standards for dispensing pharmacy within an oncology center of excellence to the order and specification of others; Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards; Testing, analysis and evaluation of dispensing pharmacy within an oncology center of excellence to determine conformity with established accreditation standards |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 25, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, October 19, 2021 |
| First Use In Commerce Date | Tuesday, October 19, 2021 |
Trademark Owner History
| Party Name | National Community Oncology Dispensing Association, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cazenovia, NY 13035 |
| Party Name | National Community Oncology Dispensing Association, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cazenovia, NY 13035 |
| Party Name | National Community Oncology Dispensing Association, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cazenovia, NY 13035 |
Trademark Events
| Event Date | Event Description |
| Monday, August 28, 2023 | NEW APPLICATION ENTERED |
| Monday, September 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 30, 2023 | ASSIGNED TO EXAMINER |
| Friday, November 3, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, November 3, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, November 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 1, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 1, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 5, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 28, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 28, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
